NCT00498186 - Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS) | Biotech Hunter

Enrollment

295

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Restless Legs Syndrome

Interventions

DRUG

Rotigotine

"Rotigotine transdermal patches once daily:~2.5cm2 (0.5mg/24 hours) 5cm2 (1mg/24 hours) 10cm2 (2mg/24 hours) 15cm2 (3mg/24 hours) 20cm2 (4mg/24 hours)"

Trial Locations (24)

35039

Marburg

Unknown

Innsbruck

Bamberg

Berlin

Bielefeld

Gelsenkirchen

Gera

Halle

Jena

Kassel

Köthen

Mittweida

München

Neubrandenburg

Oldenburg

Regensburg

Schwalmstadt-Treysa

Schwerin

Tuttlingen

Ulm

Unterhaching

Alzira

Barcelona

Madrid